Project
Inflammatory response time course, HUVEC (Wada et al., 2009)
Navigation
Downloads
Results for MXI1_MYC_MYCN
Z-value: 2.48
Motif logo
Transcription factors associated with MXI1_MYC_MYCN
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
MXI1
|
ENSG00000119950.16 | MAX interactor 1, dimerization protein |
|
MYC
|
ENSG00000136997.10 | MYC proto-oncogene, bHLH transcription factor |
|
MYCN
|
ENSG00000134323.10 | MYCN proto-oncogene, bHLH transcription factor |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| MYCN | hg19_v2_chr2_+_16080659_16080686 | -0.42 | 3.7e-02 | Click! |
| MXI1 | hg19_v2_chr10_+_111967345_111967442, hg19_v2_chr10_+_111985713_111985774 | -0.37 | 6.9e-02 | Click! |
| MYC | hg19_v2_chr8_+_128748308_128748330, hg19_v2_chr8_+_128748466_128748487 | 0.09 | 6.6e-01 | Click! |
Activity profile of MXI1_MYC_MYCN motif
Sorted Z-values of MXI1_MYC_MYCN motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr3_-_127541679 | 16.49 |
ENST00000265052.5
|
MGLL
|
monoglyceride lipase |
| chr3_-_127542051 | 16.13 |
ENST00000398104.1
|
MGLL
|
monoglyceride lipase |
| chr15_+_89182178 | 15.58 |
ENST00000559876.1
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
| chr15_+_89182156 | 15.42 |
ENST00000379224.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
| chr8_+_17354617 | 14.61 |
ENST00000470360.1
|
SLC7A2
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 |
| chr8_+_17354587 | 13.89 |
ENST00000494857.1
ENST00000522656.1 |
SLC7A2
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 |
| chr15_+_89181974 | 13.52 |
ENST00000306072.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
| chr3_-_127542021 | 13.18 |
ENST00000434178.2
|
MGLL
|
monoglyceride lipase |
| chr10_-_6019552 | 11.56 |
ENST00000379977.3
ENST00000397251.3 ENST00000397248.2 |
IL15RA
|
interleukin 15 receptor, alpha |
| chr6_+_32811885 | 10.56 |
ENST00000458296.1
ENST00000413039.1 ENST00000429600.1 ENST00000412095.1 ENST00000415067.1 ENST00000395330.1 |
TAPSAR1
PSMB9
|
TAP1 and PSMB8 antisense RNA 1 proteasome (prosome, macropain) subunit, beta type, 9 |
| chr15_+_67358163 | 10.44 |
ENST00000327367.4
|
SMAD3
|
SMAD family member 3 |
| chr3_-_127441406 | 9.85 |
ENST00000487473.1
ENST00000484451.1 |
MGLL
|
monoglyceride lipase |
| chr12_-_121734489 | 8.25 |
ENST00000412367.2
ENST00000402834.4 ENST00000404169.3 |
CAMKK2
|
calcium/calmodulin-dependent protein kinase kinase 2, beta |
| chr10_-_6019455 | 8.23 |
ENST00000530685.1
ENST00000397255.3 ENST00000379971.1 ENST00000528354.1 ENST00000397250.2 ENST00000429135.2 |
IL15RA
|
interleukin 15 receptor, alpha |
| chr21_+_26934165 | 7.85 |
ENST00000456917.1
|
MIR155HG
|
MIR155 host gene (non-protein coding) |
| chr17_+_40440481 | 7.77 |
ENST00000590726.2
ENST00000452307.2 ENST00000444283.1 ENST00000588868.1 |
STAT5A
|
signal transducer and activator of transcription 5A |
| chr4_-_2758015 | 7.47 |
ENST00000510267.1
ENST00000503235.1 ENST00000315423.7 |
TNIP2
|
TNFAIP3 interacting protein 2 |
| chr11_-_72385437 | 7.38 |
ENST00000418754.2
ENST00000542969.2 ENST00000334456.5 |
PDE2A
|
phosphodiesterase 2A, cGMP-stimulated |
| chr2_-_10588630 | 7.22 |
ENST00000234111.4
|
ODC1
|
ornithine decarboxylase 1 |
| chr19_+_45504688 | 7.21 |
ENST00000221452.8
ENST00000540120.1 ENST00000505236.1 |
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B |
| chr1_-_11120057 | 6.78 |
ENST00000376957.2
|
SRM
|
spermidine synthase |
| chr14_+_93799556 | 6.72 |
ENST00000256339.4
|
UNC79
|
unc-79 homolog (C. elegans) |
| chr11_+_69455855 | 6.60 |
ENST00000227507.2
ENST00000536559.1 |
CCND1
|
cyclin D1 |
| chr10_-_49732281 | 6.58 |
ENST00000374170.1
|
ARHGAP22
|
Rho GTPase activating protein 22 |
| chr3_+_133292851 | 6.22 |
ENST00000503932.1
|
CDV3
|
CDV3 homolog (mouse) |
| chr1_+_65613340 | 6.08 |
ENST00000546702.1
|
AK4
|
adenylate kinase 4 |
| chr17_-_36831156 | 5.90 |
ENST00000325814.5
|
C17orf96
|
chromosome 17 open reading frame 96 |
| chr17_-_74497432 | 5.73 |
ENST00000590288.1
ENST00000313080.4 ENST00000592123.1 ENST00000591255.1 ENST00000585989.1 ENST00000591697.1 ENST00000389760.4 |
RHBDF2
|
rhomboid 5 homolog 2 (Drosophila) |
| chr8_+_104383728 | 5.53 |
ENST00000330295.5
|
CTHRC1
|
collagen triple helix repeat containing 1 |
| chr19_+_10764937 | 5.50 |
ENST00000449870.1
ENST00000318511.3 ENST00000420083.1 |
ILF3
|
interleukin enhancer binding factor 3, 90kDa |
| chr6_-_32811771 | 5.48 |
ENST00000395339.3
ENST00000374882.3 |
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8 |
| chr3_+_133292759 | 5.44 |
ENST00000431519.2
|
CDV3
|
CDV3 homolog (mouse) |
| chr1_+_165797024 | 5.41 |
ENST00000372212.4
|
UCK2
|
uridine-cytidine kinase 2 |
| chr19_+_10765003 | 5.41 |
ENST00000407004.3
ENST00000589998.1 ENST00000589600.1 |
ILF3
|
interleukin enhancer binding factor 3, 90kDa |
| chr1_+_65613217 | 5.37 |
ENST00000545314.1
|
AK4
|
adenylate kinase 4 |
| chr6_+_32811861 | 5.26 |
ENST00000453426.1
|
TAPSAR1
|
TAP1 and PSMB8 antisense RNA 1 |
| chr10_+_70715884 | 5.07 |
ENST00000354185.4
|
DDX21
|
DEAD (Asp-Glu-Ala-Asp) box helicase 21 |
| chr12_+_113354341 | 4.86 |
ENST00000553152.1
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
| chr2_-_224903995 | 4.84 |
ENST00000409304.1
ENST00000454956.1 ENST00000258405.4 |
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
| chr10_+_81107271 | 4.84 |
ENST00000448165.1
|
PPIF
|
peptidylprolyl isomerase F |
| chr6_-_43197189 | 4.83 |
ENST00000509253.1
ENST00000393987.2 ENST00000230431.6 |
DNPH1
|
2'-deoxynucleoside 5'-phosphate N-hydrolase 1 |
| chr19_-_10764509 | 4.77 |
ENST00000591501.1
|
ILF3-AS1
|
ILF3 antisense RNA 1 (head to head) |
| chr5_+_110427983 | 4.39 |
ENST00000513710.2
ENST00000505303.1 |
WDR36
|
WD repeat domain 36 |
| chr11_+_19798964 | 4.38 |
ENST00000527559.2
|
NAV2
|
neuron navigator 2 |
| chr19_-_50432782 | 4.30 |
ENST00000413454.1
ENST00000596437.1 ENST00000341114.3 ENST00000595948.1 |
NUP62
IL4I1
|
nucleoporin 62kDa interleukin 4 induced 1 |
| chr1_-_212873267 | 4.28 |
ENST00000243440.1
|
BATF3
|
basic leucine zipper transcription factor, ATF-like 3 |
| chr2_-_11810284 | 4.26 |
ENST00000306928.5
|
NTSR2
|
neurotensin receptor 2 |
| chr13_+_113951607 | 4.24 |
ENST00000397181.3
|
LAMP1
|
lysosomal-associated membrane protein 1 |
| chr17_-_2614927 | 4.14 |
ENST00000435359.1
|
CLUH
|
clustered mitochondria (cluA/CLU1) homolog |
| chr19_+_676385 | 4.10 |
ENST00000166139.4
|
FSTL3
|
follistatin-like 3 (secreted glycoprotein) |
| chr15_+_89164520 | 4.07 |
ENST00000332810.3
|
AEN
|
apoptosis enhancing nuclease |
| chr1_+_65613513 | 4.03 |
ENST00000395334.2
|
AK4
|
adenylate kinase 4 |
| chr3_+_133293278 | 4.02 |
ENST00000508481.1
ENST00000420115.2 ENST00000504867.1 ENST00000507408.1 ENST00000511392.1 ENST00000515421.1 |
CDV3
|
CDV3 homolog (mouse) |
| chr17_+_77030267 | 4.00 |
ENST00000581774.1
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1 |
| chr10_-_49701686 | 3.95 |
ENST00000417247.2
|
ARHGAP22
|
Rho GTPase activating protein 22 |
| chr1_+_227058264 | 3.92 |
ENST00000366783.3
ENST00000340188.4 ENST00000495488.1 ENST00000422240.2 |
PSEN2
|
presenilin 2 (Alzheimer disease 4) |
| chr15_-_101835110 | 3.86 |
ENST00000560496.1
|
SNRPA1
|
small nuclear ribonucleoprotein polypeptide A' |
| chr10_+_6244829 | 3.85 |
ENST00000317350.4
ENST00000379785.1 ENST00000379782.3 ENST00000360521.2 ENST00000379775.4 |
PFKFB3
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
| chr3_+_119187785 | 3.85 |
ENST00000295588.4
ENST00000476573.1 |
POGLUT1
|
protein O-glucosyltransferase 1 |
| chr15_+_62359175 | 3.85 |
ENST00000355522.5
|
C2CD4A
|
C2 calcium-dependent domain containing 4A |
| chr20_+_55966444 | 3.83 |
ENST00000356208.5
ENST00000440234.2 |
RBM38
|
RNA binding motif protein 38 |
| chr19_+_45582453 | 3.81 |
ENST00000591607.1
ENST00000591747.1 ENST00000270257.4 ENST00000391951.2 ENST00000587566.1 |
GEMIN7
MARK4
|
gem (nuclear organelle) associated protein 7 MAP/microtubule affinity-regulating kinase 4 |
| chr1_+_154193325 | 3.81 |
ENST00000428931.1
ENST00000441890.1 ENST00000271877.7 ENST00000412596.1 ENST00000368504.1 ENST00000437652.1 |
UBAP2L
|
ubiquitin associated protein 2-like |
| chr19_-_5720248 | 3.78 |
ENST00000360614.3
|
LONP1
|
lon peptidase 1, mitochondrial |
| chr7_-_2354099 | 3.78 |
ENST00000222990.3
|
SNX8
|
sorting nexin 8 |
| chr8_+_123793633 | 3.77 |
ENST00000314393.4
|
ZHX2
|
zinc fingers and homeoboxes 2 |
| chr16_+_57023406 | 3.72 |
ENST00000262510.6
ENST00000308149.7 ENST00000436936.1 |
NLRC5
|
NLR family, CARD domain containing 5 |
| chr19_-_50432654 | 3.69 |
ENST00000596680.1
ENST00000594673.1 ENST00000597029.1 |
NUP62
|
nucleoporin 62kDa |
| chr15_+_98503922 | 3.61 |
ENST00000268042.6
|
ARRDC4
|
arrestin domain containing 4 |
| chr1_-_31712401 | 3.58 |
ENST00000373736.2
|
NKAIN1
|
Na+/K+ transporting ATPase interacting 1 |
| chr13_+_26828275 | 3.57 |
ENST00000381527.3
|
CDK8
|
cyclin-dependent kinase 8 |
| chr10_-_71993176 | 3.56 |
ENST00000373232.3
|
PPA1
|
pyrophosphatase (inorganic) 1 |
| chr11_-_126081532 | 3.55 |
ENST00000533628.1
ENST00000298317.4 ENST00000532674.1 |
RPUSD4
|
RNA pseudouridylate synthase domain containing 4 |
| chr1_+_165796753 | 3.55 |
ENST00000367879.4
|
UCK2
|
uridine-cytidine kinase 2 |
| chr14_-_24658053 | 3.55 |
ENST00000354464.6
|
IPO4
|
importin 4 |
| chr16_-_67969888 | 3.52 |
ENST00000574576.2
|
PSMB10
|
proteasome (prosome, macropain) subunit, beta type, 10 |
| chr22_-_50964558 | 3.50 |
ENST00000535425.1
ENST00000439934.1 |
SCO2
|
SCO2 cytochrome c oxidase assembly protein |
| chr1_+_44445549 | 3.46 |
ENST00000356836.6
|
B4GALT2
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2 |
| chr15_-_40213080 | 3.45 |
ENST00000561100.1
|
GPR176
|
G protein-coupled receptor 176 |
| chr15_-_41408339 | 3.44 |
ENST00000401393.3
|
INO80
|
INO80 complex subunit |
| chr1_+_65613852 | 3.42 |
ENST00000327299.7
|
AK4
|
adenylate kinase 4 |
| chr12_-_58146048 | 3.41 |
ENST00000547281.1
ENST00000546489.1 ENST00000552388.1 ENST00000540325.1 ENST00000312990.6 |
CDK4
|
cyclin-dependent kinase 4 |
| chr8_+_104426942 | 3.40 |
ENST00000297579.5
|
DCAF13
|
DDB1 and CUL4 associated factor 13 |
| chr8_-_104427313 | 3.40 |
ENST00000297578.4
|
SLC25A32
|
solute carrier family 25 (mitochondrial folate carrier), member 32 |
| chr2_-_10587897 | 3.39 |
ENST00000405333.1
ENST00000443218.1 |
ODC1
|
ornithine decarboxylase 1 |
| chrX_-_13956497 | 3.39 |
ENST00000398361.3
|
GPM6B
|
glycoprotein M6B |
| chr12_-_58146128 | 3.36 |
ENST00000551800.1
ENST00000549606.1 ENST00000257904.6 |
CDK4
|
cyclin-dependent kinase 4 |
| chr4_-_177713788 | 3.36 |
ENST00000280193.2
|
VEGFC
|
vascular endothelial growth factor C |
| chr10_-_49812997 | 3.36 |
ENST00000417912.2
|
ARHGAP22
|
Rho GTPase activating protein 22 |
| chr2_-_225907150 | 3.33 |
ENST00000258390.7
|
DOCK10
|
dedicator of cytokinesis 10 |
| chr21_+_43639211 | 3.33 |
ENST00000450121.1
ENST00000398449.3 ENST00000361802.2 |
ABCG1
|
ATP-binding cassette, sub-family G (WHITE), member 1 |
| chr2_+_32853093 | 3.32 |
ENST00000448773.1
ENST00000317907.4 |
TTC27
|
tetratricopeptide repeat domain 27 |
| chr1_-_111991850 | 3.30 |
ENST00000411751.2
|
WDR77
|
WD repeat domain 77 |
| chr6_+_30539153 | 3.30 |
ENST00000326195.8
ENST00000376545.3 ENST00000396515.4 ENST00000441867.1 ENST00000468958.1 |
ABCF1
|
ATP-binding cassette, sub-family F (GCN20), member 1 |
| chr16_-_87903079 | 3.28 |
ENST00000261622.4
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
| chr5_-_150460539 | 3.25 |
ENST00000520931.1
ENST00000520695.1 ENST00000521591.1 ENST00000518977.1 |
TNIP1
|
TNFAIP3 interacting protein 1 |
| chr7_-_22396533 | 3.25 |
ENST00000344041.6
|
RAPGEF5
|
Rap guanine nucleotide exchange factor (GEF) 5 |
| chr12_-_49463753 | 3.24 |
ENST00000301068.6
|
RHEBL1
|
Ras homolog enriched in brain like 1 |
| chr1_-_1149506 | 3.24 |
ENST00000379236.3
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4 |
| chr11_+_34127142 | 3.20 |
ENST00000257829.3
ENST00000531159.2 |
NAT10
|
N-acetyltransferase 10 (GCN5-related) |
| chr3_-_50329835 | 3.17 |
ENST00000429673.2
|
IFRD2
|
interferon-related developmental regulator 2 |
| chr4_-_681114 | 3.14 |
ENST00000503156.1
|
MFSD7
|
major facilitator superfamily domain containing 7 |
| chr14_-_65569186 | 3.11 |
ENST00000555932.1
ENST00000358664.4 ENST00000284165.6 ENST00000358402.4 ENST00000246163.2 ENST00000556979.1 ENST00000555667.1 ENST00000557746.1 ENST00000556443.1 |
MAX
|
MYC associated factor X |
| chr18_+_23806437 | 3.11 |
ENST00000578121.1
|
TAF4B
|
TAF4b RNA polymerase II, TATA box binding protein (TBP)-associated factor, 105kDa |
| chr11_+_17741111 | 3.11 |
ENST00000250003.3
|
MYOD1
|
myogenic differentiation 1 |
| chr15_-_70390191 | 3.10 |
ENST00000559191.1
|
TLE3
|
transducin-like enhancer of split 3 (E(sp1) homolog, Drosophila) |
| chr2_-_7005785 | 3.09 |
ENST00000256722.5
ENST00000404168.1 ENST00000458098.1 |
CMPK2
|
cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial |
| chr15_-_101835414 | 3.09 |
ENST00000254193.6
|
SNRPA1
|
small nuclear ribonucleoprotein polypeptide A' |
| chr19_+_49458107 | 3.04 |
ENST00000539787.1
ENST00000345358.7 ENST00000391871.3 ENST00000415969.2 ENST00000354470.3 ENST00000506183.1 ENST00000293288.8 |
BAX
|
BCL2-associated X protein |
| chr17_-_41623716 | 3.04 |
ENST00000319349.5
|
ETV4
|
ets variant 4 |
| chr17_-_74722536 | 3.03 |
ENST00000585429.1
|
JMJD6
|
jumonji domain containing 6 |
| chr11_-_117698765 | 3.00 |
ENST00000532119.1
|
FXYD2
|
FXYD domain containing ion transport regulator 2 |
| chr19_-_50432711 | 3.00 |
ENST00000597723.1
ENST00000599788.1 ENST00000596217.1 ENST00000593652.1 ENST00000599567.1 ENST00000600935.1 ENST00000596011.1 ENST00000596022.1 ENST00000597295.1 |
NUP62
IL4I1
|
nucleoporin 62kDa interleukin 4 induced 1 |
| chr20_+_61273797 | 2.99 |
ENST00000217159.1
|
SLCO4A1
|
solute carrier organic anion transporter family, member 4A1 |
| chr19_+_17666403 | 2.99 |
ENST00000252599.4
|
COLGALT1
|
collagen beta(1-O)galactosyltransferase 1 |
| chr18_-_71959159 | 2.96 |
ENST00000494131.2
ENST00000397914.4 ENST00000340533.4 |
CYB5A
|
cytochrome b5 type A (microsomal) |
| chr19_-_36705547 | 2.96 |
ENST00000304116.5
|
ZNF565
|
zinc finger protein 565 |
| chr5_+_34656569 | 2.93 |
ENST00000428746.2
|
RAI14
|
retinoic acid induced 14 |
| chr9_-_136203235 | 2.93 |
ENST00000372022.4
|
SURF6
|
surfeit 6 |
| chr12_+_66217911 | 2.93 |
ENST00000403681.2
|
HMGA2
|
high mobility group AT-hook 2 |
| chr5_+_34656331 | 2.90 |
ENST00000265109.3
|
RAI14
|
retinoic acid induced 14 |
| chr10_+_90750493 | 2.89 |
ENST00000357339.2
ENST00000355279.2 |
FAS
|
Fas cell surface death receptor |
| chr19_-_5720123 | 2.89 |
ENST00000587365.1
ENST00000585374.1 ENST00000593119.1 |
LONP1
|
lon peptidase 1, mitochondrial |
| chr15_-_70390213 | 2.87 |
ENST00000557997.1
ENST00000317509.8 ENST00000442299.2 |
TLE3
|
transducin-like enhancer of split 3 (E(sp1) homolog, Drosophila) |
| chr19_-_5719860 | 2.87 |
ENST00000590729.1
|
LONP1
|
lon peptidase 1, mitochondrial |
| chr2_+_232063260 | 2.85 |
ENST00000349938.4
|
ARMC9
|
armadillo repeat containing 9 |
| chr2_+_192543153 | 2.84 |
ENST00000425611.2
|
NABP1
|
nucleic acid binding protein 1 |
| chr22_-_50963976 | 2.83 |
ENST00000252785.3
ENST00000395693.3 |
SCO2
|
SCO2 cytochrome c oxidase assembly protein |
| chr8_-_70745575 | 2.83 |
ENST00000524945.1
|
SLCO5A1
|
solute carrier organic anion transporter family, member 5A1 |
| chr6_+_32812568 | 2.82 |
ENST00000414474.1
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9 |
| chr5_+_176730769 | 2.80 |
ENST00000303204.4
ENST00000503216.1 |
PRELID1
|
PRELI domain containing 1 |
| chr5_+_131409476 | 2.80 |
ENST00000296871.2
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage) |
| chr1_+_15671580 | 2.78 |
ENST00000529606.1
ENST00000314740.8 |
FHAD1
|
forkhead-associated (FHA) phosphopeptide binding domain 1 |
| chr6_-_43543702 | 2.77 |
ENST00000265351.7
|
XPO5
|
exportin 5 |
| chr19_+_6739662 | 2.77 |
ENST00000313285.8
ENST00000313244.9 ENST00000596758.1 |
TRIP10
|
thyroid hormone receptor interactor 10 |
| chr1_-_155232221 | 2.77 |
ENST00000355379.3
|
SCAMP3
|
secretory carrier membrane protein 3 |
| chr1_+_1167594 | 2.76 |
ENST00000379198.2
|
B3GALT6
|
UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6 |
| chr12_-_58165870 | 2.73 |
ENST00000257848.7
|
METTL1
|
methyltransferase like 1 |
| chr2_+_55459808 | 2.72 |
ENST00000404735.1
|
RPS27A
|
ribosomal protein S27a |
| chr8_+_22224811 | 2.68 |
ENST00000381237.1
|
SLC39A14
|
solute carrier family 39 (zinc transporter), member 14 |
| chr21_-_45660723 | 2.68 |
ENST00000344330.4
ENST00000407780.3 ENST00000400379.3 |
ICOSLG
|
inducible T-cell co-stimulator ligand |
| chr14_+_73393040 | 2.68 |
ENST00000358377.2
ENST00000353777.3 ENST00000394234.2 ENST00000509153.1 ENST00000555042.1 |
DCAF4
|
DDB1 and CUL4 associated factor 4 |
| chr8_-_8751068 | 2.67 |
ENST00000276282.6
|
MFHAS1
|
malignant fibrous histiocytoma amplified sequence 1 |
| chr3_-_107777208 | 2.66 |
ENST00000398258.3
|
CD47
|
CD47 molecule |
| chr7_+_916183 | 2.64 |
ENST00000265857.3
|
GET4
|
golgi to ER traffic protein 4 homolog (S. cerevisiae) |
| chr1_-_155232047 | 2.64 |
ENST00000302631.3
|
SCAMP3
|
secretory carrier membrane protein 3 |
| chr7_-_27170352 | 2.63 |
ENST00000428284.2
ENST00000360046.5 |
HOXA4
|
homeobox A4 |
| chr12_+_6833237 | 2.62 |
ENST00000229251.3
ENST00000539735.1 ENST00000538410.1 |
COPS7A
|
COP9 signalosome subunit 7A |
| chr5_+_70883117 | 2.57 |
ENST00000340941.6
|
MCCC2
|
methylcrotonoyl-CoA carboxylase 2 (beta) |
| chr3_-_107809816 | 2.56 |
ENST00000361309.5
ENST00000355354.7 |
CD47
|
CD47 molecule |
| chr1_+_166808692 | 2.56 |
ENST00000367876.4
|
POGK
|
pogo transposable element with KRAB domain |
| chr16_+_56642489 | 2.53 |
ENST00000561491.1
|
MT2A
|
metallothionein 2A |
| chr3_+_133292574 | 2.53 |
ENST00000264993.3
|
CDV3
|
CDV3 homolog (mouse) |
| chr17_-_33469299 | 2.53 |
ENST00000586869.1
ENST00000360831.5 ENST00000442241.4 |
NLE1
|
notchless homolog 1 (Drosophila) |
| chr2_+_131100710 | 2.52 |
ENST00000452955.1
|
IMP4
|
IMP4, U3 small nucleolar ribonucleoprotein, homolog (yeast) |
| chr19_-_10530784 | 2.51 |
ENST00000593124.1
|
CDC37
|
cell division cycle 37 |
| chr11_+_35639735 | 2.51 |
ENST00000317811.4
|
FJX1
|
four jointed box 1 (Drosophila) |
| chr5_-_158636512 | 2.51 |
ENST00000424310.2
|
RNF145
|
ring finger protein 145 |
| chr9_-_2844058 | 2.50 |
ENST00000397885.2
|
KIAA0020
|
KIAA0020 |
| chr8_+_22224760 | 2.50 |
ENST00000359741.5
ENST00000520644.1 ENST00000240095.6 |
SLC39A14
|
solute carrier family 39 (zinc transporter), member 14 |
| chr5_+_70883178 | 2.48 |
ENST00000323375.8
|
MCCC2
|
methylcrotonoyl-CoA carboxylase 2 (beta) |
| chr19_+_50180507 | 2.48 |
ENST00000454376.2
ENST00000524771.1 |
PRMT1
|
protein arginine methyltransferase 1 |
| chr10_+_60028818 | 2.47 |
ENST00000333926.5
|
CISD1
|
CDGSH iron sulfur domain 1 |
| chr3_-_51975942 | 2.45 |
ENST00000232888.6
|
RRP9
|
ribosomal RNA processing 9, small subunit (SSU) processome component, homolog (yeast) |
| chr17_-_40540586 | 2.45 |
ENST00000264657.5
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor) |
| chr1_+_1243947 | 2.45 |
ENST00000379031.5
|
PUSL1
|
pseudouridylate synthase-like 1 |
| chr16_+_84328252 | 2.44 |
ENST00000219454.5
|
WFDC1
|
WAP four-disulfide core domain 1 |
| chr3_-_49967292 | 2.44 |
ENST00000455683.2
|
MON1A
|
MON1 secretory trafficking family member A |
| chr4_+_110736659 | 2.43 |
ENST00000394631.3
ENST00000226796.6 |
GAR1
|
GAR1 ribonucleoprotein |
| chr16_+_29467127 | 2.41 |
ENST00000344620.6
|
SULT1A4
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4 |
| chr10_-_79789291 | 2.40 |
ENST00000372371.3
|
POLR3A
|
polymerase (RNA) III (DNA directed) polypeptide A, 155kDa |
| chr14_+_24630465 | 2.40 |
ENST00000557894.1
ENST00000559284.1 ENST00000560275.1 |
IRF9
|
interferon regulatory factor 9 |
| chr2_+_127413481 | 2.38 |
ENST00000259254.4
|
GYPC
|
glycophorin C (Gerbich blood group) |
| chr14_-_65569057 | 2.38 |
ENST00000555419.1
ENST00000341653.2 |
MAX
|
MYC associated factor X |
| chr20_+_23331373 | 2.38 |
ENST00000254998.2
|
NXT1
|
NTF2-like export factor 1 |
| chr19_+_10812108 | 2.37 |
ENST00000250237.5
ENST00000592254.1 |
QTRT1
|
queuine tRNA-ribosyltransferase 1 |
| chr12_+_101673872 | 2.36 |
ENST00000261637.4
|
UTP20
|
UTP20, small subunit (SSU) processome component, homolog (yeast) |
| chr12_+_6833437 | 2.36 |
ENST00000534947.1
ENST00000541866.1 ENST00000534877.1 ENST00000538753.1 |
COPS7A
|
COP9 signalosome subunit 7A |
| chr19_-_44160768 | 2.35 |
ENST00000593447.1
|
PLAUR
|
plasminogen activator, urokinase receptor |
| chr12_+_54519842 | 2.35 |
ENST00000508564.1
|
RP11-834C11.4
|
RP11-834C11.4 |
| chr9_+_100174344 | 2.34 |
ENST00000422139.2
|
TDRD7
|
tudor domain containing 7 |
| chr6_+_31865552 | 2.34 |
ENST00000469372.1
ENST00000497706.1 |
C2
|
complement component 2 |
| chr1_-_156721502 | 2.34 |
ENST00000357325.5
|
HDGF
|
hepatoma-derived growth factor |
| chr14_+_105155925 | 2.34 |
ENST00000330634.7
ENST00000398337.4 ENST00000392634.4 |
INF2
|
inverted formin, FH2 and WH2 domain containing |
| chr9_-_136857403 | 2.33 |
ENST00000406606.3
ENST00000371850.3 |
VAV2
|
vav 2 guanine nucleotide exchange factor |
| chr22_+_38302285 | 2.33 |
ENST00000215957.6
|
MICALL1
|
MICAL-like 1 |
| chr2_+_131100423 | 2.30 |
ENST00000409935.1
ENST00000409649.1 ENST00000428740.1 |
IMP4
|
IMP4, U3 small nucleolar ribonucleoprotein, homolog (yeast) |
| chr7_-_27169801 | 2.28 |
ENST00000511914.1
|
HOXA4
|
homeobox A4 |
| chr8_+_22102611 | 2.28 |
ENST00000306433.4
|
POLR3D
|
polymerase (RNA) III (DNA directed) polypeptide D, 44kDa |
| chr2_-_120124258 | 2.28 |
ENST00000409877.1
ENST00000409523.1 ENST00000409466.2 ENST00000414534.1 |
C2orf76
|
chromosome 2 open reading frame 76 |
| chr17_-_76836729 | 2.24 |
ENST00000587783.1
ENST00000542802.3 ENST00000586531.1 ENST00000589424.1 ENST00000590546.2 |
USP36
|
ubiquitin specific peptidase 36 |
| chr17_+_42148225 | 2.24 |
ENST00000591696.1
|
G6PC3
|
glucose 6 phosphatase, catalytic, 3 |
| chr20_+_61299155 | 2.22 |
ENST00000451793.1
|
SLCO4A1
|
solute carrier organic anion transporter family, member 4A1 |
| chr7_-_131241361 | 2.21 |
ENST00000378555.3
ENST00000322985.9 ENST00000541194.1 ENST00000537928.1 |
PODXL
|
podocalyxin-like |
| chr11_+_61957687 | 2.21 |
ENST00000306238.3
|
SCGB1D1
|
secretoglobin, family 1D, member 1 |
| chr8_+_11627205 | 2.21 |
ENST00000455213.2
ENST00000403422.3 ENST00000528323.1 ENST00000284503.6 |
NEIL2
|
nei endonuclease VIII-like 2 (E. coli) |
| chr19_+_50180409 | 2.21 |
ENST00000391851.4
|
PRMT1
|
protein arginine methyltransferase 1 |
| chr11_-_64646086 | 2.21 |
ENST00000320631.3
|
EHD1
|
EH-domain containing 1 |
| chr19_+_18284477 | 2.20 |
ENST00000407280.3
|
IFI30
|
interferon, gamma-inducible protein 30 |
| chr13_+_113951532 | 2.20 |
ENST00000332556.4
|
LAMP1
|
lysosomal-associated membrane protein 1 |
Network of associatons between targets according to the STRING database.
First level regulatory network of MXI1_MYC_MYCN
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 9.5 | 28.5 | GO:1903410 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
| 9.0 | 45.1 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 7.9 | 55.6 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 3.2 | 9.5 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
| 2.7 | 11.0 | GO:1903438 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 2.7 | 10.6 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
| 2.2 | 9.0 | GO:0046035 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 2.1 | 10.4 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
| 1.9 | 18.9 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 1.8 | 7.4 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 1.8 | 5.5 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
| 1.8 | 7.1 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 1.7 | 8.3 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 1.6 | 1.6 | GO:0042704 | uterine wall breakdown(GO:0042704) |
| 1.6 | 1.6 | GO:0043132 | NAD transport(GO:0043132) |
| 1.6 | 4.8 | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 1.6 | 6.4 | GO:0043323 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 1.5 | 3.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
| 1.3 | 3.8 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 1.2 | 3.7 | GO:0060058 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 1.2 | 7.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 1.2 | 3.6 | GO:0015883 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
| 1.2 | 2.4 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
| 1.1 | 4.6 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 1.1 | 6.8 | GO:1904637 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 1.1 | 3.2 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
| 1.1 | 6.4 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 1.1 | 3.2 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 1.1 | 3.2 | GO:0034471 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 1.1 | 3.2 | GO:0060901 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 1.0 | 3.1 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 1.0 | 7.0 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 1.0 | 4.8 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 1.0 | 3.8 | GO:0035978 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
| 0.9 | 0.9 | GO:1902908 | regulation of melanosome transport(GO:1902908) |
| 0.9 | 2.8 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.9 | 8.4 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
| 0.9 | 5.4 | GO:0036337 | Fas signaling pathway(GO:0036337) |
| 0.9 | 3.6 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
| 0.9 | 6.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.9 | 3.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.9 | 5.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.9 | 2.6 | GO:0008355 | olfactory learning(GO:0008355) |
| 0.9 | 2.6 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.8 | 5.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.8 | 3.3 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
| 0.8 | 2.5 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.8 | 2.5 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.8 | 6.5 | GO:0021564 | vagus nerve development(GO:0021564) |
| 0.8 | 3.3 | GO:0052027 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.8 | 3.2 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.8 | 3.2 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.8 | 5.5 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
| 0.8 | 3.1 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.8 | 3.0 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.7 | 3.0 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.7 | 3.7 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.7 | 4.3 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.7 | 2.1 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.7 | 2.1 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.7 | 2.1 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
| 0.7 | 9.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.7 | 8.7 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.7 | 3.4 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
| 0.7 | 5.2 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
| 0.6 | 2.6 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.6 | 2.6 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.6 | 1.9 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 0.6 | 1.9 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
| 0.6 | 1.8 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.6 | 0.6 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.6 | 2.3 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.6 | 5.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.6 | 2.3 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.6 | 1.1 | GO:1904170 | regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
| 0.6 | 2.8 | GO:0045918 | positive regulation of interleukin-23 production(GO:0032747) negative regulation of cytolysis(GO:0045918) |
| 0.6 | 1.1 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.6 | 2.2 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.6 | 10.0 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.6 | 0.6 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.5 | 1.6 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
| 0.5 | 1.6 | GO:0001207 | histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
| 0.5 | 0.5 | GO:0089709 | histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
| 0.5 | 2.7 | GO:0009608 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
| 0.5 | 1.1 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.5 | 2.6 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.5 | 2.0 | GO:0010585 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.5 | 4.5 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.5 | 1.0 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.5 | 1.5 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
| 0.5 | 8.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.5 | 1.5 | GO:1904617 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 0.5 | 1.5 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
| 0.5 | 1.0 | GO:0005989 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
| 0.5 | 3.8 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 0.5 | 1.4 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.5 | 0.9 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 0.5 | 3.8 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.5 | 1.4 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.5 | 0.5 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.5 | 1.4 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.5 | 3.2 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 0.5 | 1.4 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
| 0.5 | 1.4 | GO:1902941 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) regulation of voltage-gated chloride channel activity(GO:1902941) positive regulation of voltage-gated chloride channel activity(GO:1902943) |
| 0.5 | 6.0 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.5 | 2.3 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.5 | 3.7 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.5 | 1.4 | GO:1904897 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.5 | 0.5 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.4 | 2.7 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
| 0.4 | 1.7 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 0.4 | 1.3 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.4 | 2.2 | GO:0072619 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.4 | 0.9 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
| 0.4 | 1.3 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 0.4 | 3.3 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.4 | 1.7 | GO:0072302 | negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
| 0.4 | 2.5 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
| 0.4 | 1.6 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.4 | 1.6 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.4 | 1.6 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.4 | 2.8 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.4 | 4.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.4 | 1.2 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.4 | 7.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.4 | 0.8 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.4 | 1.2 | GO:0018011 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.4 | 2.0 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.4 | 0.8 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
| 0.4 | 1.6 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
| 0.4 | 1.9 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.4 | 0.4 | GO:0006424 | glutamyl-tRNA aminoacylation(GO:0006424) |
| 0.4 | 1.9 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.4 | 2.7 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.4 | 1.9 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
| 0.4 | 3.0 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.4 | 1.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
| 0.4 | 6.0 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.4 | 1.1 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.4 | 1.1 | GO:0032764 | heme oxidation(GO:0006788) smooth muscle hyperplasia(GO:0014806) negative regulation of mast cell cytokine production(GO:0032764) |
| 0.4 | 11.2 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.4 | 1.9 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.4 | 1.8 | GO:0051182 | coenzyme transport(GO:0051182) |
| 0.4 | 1.8 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.4 | 1.5 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.4 | 1.4 | GO:0090298 | base-excision repair, DNA ligation(GO:0006288) negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
| 0.4 | 1.1 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
| 0.4 | 0.7 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
| 0.4 | 2.9 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 0.4 | 1.1 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.4 | 1.1 | GO:1902080 | positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 0.4 | 1.8 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.4 | 3.2 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.4 | 3.5 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.4 | 1.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 0.3 | 2.8 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.3 | 0.7 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
| 0.3 | 3.4 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.3 | 5.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
| 0.3 | 2.4 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.3 | 3.7 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
| 0.3 | 1.7 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.3 | 1.3 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
| 0.3 | 1.0 | GO:0003285 | septum secundum development(GO:0003285) |
| 0.3 | 1.0 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 0.3 | 2.0 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.3 | 0.3 | GO:2000974 | negative regulation of pro-B cell differentiation(GO:2000974) |
| 0.3 | 1.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.3 | 1.3 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.3 | 2.9 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.3 | 3.2 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
| 0.3 | 3.8 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.3 | 1.9 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.3 | 1.2 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
| 0.3 | 1.2 | GO:0009386 | translational attenuation(GO:0009386) |
| 0.3 | 1.9 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
| 0.3 | 1.9 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.3 | 0.6 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.3 | 1.2 | GO:0043126 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.3 | 1.5 | GO:1902731 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) negative regulation of chondrocyte proliferation(GO:1902731) |
| 0.3 | 1.5 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
| 0.3 | 1.8 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 0.3 | 0.9 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 0.3 | 1.2 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.3 | 1.5 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.3 | 1.5 | GO:0034227 | tRNA thio-modification(GO:0034227) |
| 0.3 | 1.5 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
| 0.3 | 0.9 | GO:0007412 | axon target recognition(GO:0007412) |
| 0.3 | 1.8 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 0.3 | 1.2 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
| 0.3 | 0.9 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
| 0.3 | 1.2 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.3 | 1.4 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.3 | 5.4 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
| 0.3 | 2.6 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.3 | 4.8 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.3 | 2.3 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.3 | 0.8 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.3 | 1.4 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.3 | 1.7 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.3 | 2.8 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.3 | 2.2 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.3 | 2.5 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) |
| 0.3 | 32.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.3 | 0.5 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
| 0.3 | 1.3 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.3 | 5.3 | GO:0008228 | opsonization(GO:0008228) |
| 0.3 | 0.3 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
| 0.3 | 1.1 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.3 | 1.3 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.3 | 0.8 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.3 | 2.4 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.3 | 2.1 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 0.3 | 1.3 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.3 | 3.6 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.3 | 2.6 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.3 | 1.3 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
| 0.3 | 2.1 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.3 | 1.0 | GO:1901355 | response to rapamycin(GO:1901355) |
| 0.3 | 3.1 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.3 | 1.5 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.3 | 3.1 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 0.3 | 0.5 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
| 0.3 | 2.8 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.3 | 1.3 | GO:0014028 | notochord formation(GO:0014028) |
| 0.2 | 0.7 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
| 0.2 | 0.5 | GO:0046098 | guanine metabolic process(GO:0046098) |
| 0.2 | 1.5 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.2 | 5.2 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.2 | 1.7 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.2 | 1.0 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.2 | 0.5 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
| 0.2 | 1.0 | GO:0002879 | positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
| 0.2 | 0.5 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
| 0.2 | 1.4 | GO:0060992 | response to fungicide(GO:0060992) |
| 0.2 | 0.7 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 0.2 | 2.8 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 0.2 | 0.5 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
| 0.2 | 4.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
| 0.2 | 1.8 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.2 | 0.5 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.2 | 1.4 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.2 | 18.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.2 | 0.9 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.2 | 0.7 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.2 | 0.7 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.2 | 1.8 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.2 | 1.8 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 0.2 | 0.4 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
| 0.2 | 0.9 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.2 | 0.7 | GO:1903936 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
| 0.2 | 2.0 | GO:0048311 | mitochondrion distribution(GO:0048311) |
| 0.2 | 0.9 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.2 | 0.7 | GO:2000364 | regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
| 0.2 | 0.7 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
| 0.2 | 0.4 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.2 | 7.5 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.2 | 1.7 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.2 | 0.9 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.2 | 0.2 | GO:1902957 | negative regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902957) |
| 0.2 | 1.3 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.2 | 0.6 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.2 | 1.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.2 | 1.7 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.2 | 3.6 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
| 0.2 | 0.8 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.2 | 2.1 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.2 | 0.2 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.2 | 5.4 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.2 | 3.9 | GO:0009303 | rRNA transcription(GO:0009303) |
| 0.2 | 1.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.2 | 0.8 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.2 | 0.6 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.2 | 0.4 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.2 | 0.6 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
| 0.2 | 1.4 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.2 | 1.8 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
| 0.2 | 0.8 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.2 | 0.6 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
| 0.2 | 1.8 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.2 | 0.2 | GO:0032425 | positive regulation of mismatch repair(GO:0032425) |
| 0.2 | 0.4 | GO:0003343 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
| 0.2 | 0.8 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.2 | 1.8 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.2 | 2.0 | GO:0006882 | cellular zinc ion homeostasis(GO:0006882) |
| 0.2 | 1.0 | GO:0060611 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
| 0.2 | 10.0 | GO:1903146 | regulation of mitophagy(GO:1903146) |
| 0.2 | 1.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.2 | 1.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
| 0.2 | 1.7 | GO:0032782 | bile acid secretion(GO:0032782) |
| 0.2 | 0.6 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
| 0.2 | 1.3 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.2 | 0.9 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.2 | 1.3 | GO:0015074 | DNA integration(GO:0015074) |
| 0.2 | 0.9 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.2 | 0.7 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.2 | 2.0 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
| 0.2 | 0.7 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
| 0.2 | 1.5 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.2 | 0.7 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.2 | 0.7 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.2 | 1.1 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
| 0.2 | 0.4 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.2 | 0.5 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.2 | 2.0 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.2 | 4.5 | GO:0061157 | mRNA destabilization(GO:0061157) |
| 0.2 | 0.7 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.2 | 0.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.2 | 0.2 | GO:0044026 | DNA hypermethylation(GO:0044026) |
| 0.2 | 0.5 | GO:1903568 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.2 | 2.9 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
| 0.2 | 0.4 | GO:0070487 | monocyte aggregation(GO:0070487) |
| 0.2 | 1.2 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
| 0.2 | 0.9 | GO:0046075 | dTTP metabolic process(GO:0046075) |
| 0.2 | 1.4 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.2 | 2.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.2 | 0.9 | GO:0035799 | ureter maturation(GO:0035799) |
| 0.2 | 0.9 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.2 | 2.1 | GO:0009650 | UV protection(GO:0009650) |
| 0.2 | 0.5 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.2 | 0.7 | GO:0061743 | motor learning(GO:0061743) |
| 0.2 | 0.5 | GO:2000452 | CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 0.2 | 0.5 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) mitochondrial tRNA 3'-end processing(GO:1990180) |
| 0.2 | 2.6 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.2 | 0.9 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
| 0.2 | 0.7 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
| 0.2 | 0.2 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.2 | 1.0 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.2 | 0.7 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.2 | 2.0 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.2 | 0.5 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
| 0.2 | 0.5 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.2 | 2.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
| 0.2 | 0.3 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
| 0.2 | 2.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.2 | 5.6 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.2 | 2.0 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.2 | 2.1 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.2 | 0.5 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.2 | 1.0 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.2 | 0.7 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
| 0.2 | 5.0 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
| 0.2 | 0.5 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
| 0.2 | 0.6 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
| 0.2 | 1.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.2 | 1.4 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
| 0.2 | 0.5 | GO:1904397 | negative regulation of neuromuscular junction development(GO:1904397) |
| 0.2 | 0.3 | GO:0061054 | Spemann organizer formation(GO:0060061) dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) |
| 0.2 | 1.3 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.2 | 0.3 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.2 | 1.4 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) |
| 0.2 | 0.9 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.2 | 0.3 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 0.2 | 1.3 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 0.2 | 0.6 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
| 0.2 | 3.8 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.2 | 1.1 | GO:0021831 | embryonic olfactory bulb interneuron precursor migration(GO:0021831) |
| 0.2 | 0.3 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
| 0.2 | 3.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.2 | 0.6 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
| 0.2 | 0.3 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.2 | 0.6 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
| 0.2 | 0.9 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
| 0.2 | 1.1 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.2 | 0.6 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.2 | 2.6 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.2 | 5.0 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.2 | 0.5 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
| 0.2 | 2.6 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.2 | 1.5 | GO:0060022 | hard palate development(GO:0060022) |
| 0.1 | 6.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.1 | 2.4 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
| 0.1 | 0.4 | GO:0045649 | regulation of macrophage differentiation(GO:0045649) |
| 0.1 | 2.9 | GO:0048569 | post-embryonic organ development(GO:0048569) |
| 0.1 | 2.2 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.1 | 5.8 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
| 0.1 | 0.3 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
| 0.1 | 11.1 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
| 0.1 | 0.4 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.1 | 0.4 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.1 | 0.1 | GO:0010193 | response to ozone(GO:0010193) |
| 0.1 | 0.7 | GO:0010732 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 0.1 | 1.1 | GO:0051583 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.1 | 0.7 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.1 | 2.4 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.1 | 1.1 | GO:0043587 | tongue morphogenesis(GO:0043587) |
| 0.1 | 0.4 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 0.1 | 0.7 | GO:0015692 | lead ion transport(GO:0015692) |
| 0.1 | 1.0 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
| 0.1 | 1.8 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.1 | 0.7 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 0.1 | 0.6 | GO:0090301 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.1 | 1.4 | GO:0009414 | response to water deprivation(GO:0009414) |
| 0.1 | 0.4 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.1 | 1.6 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 0.1 | 0.1 | GO:0070417 | cellular response to cold(GO:0070417) |
| 0.1 | 0.5 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.1 | 0.8 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.1 | 0.7 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.1 | 0.8 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.1 | 0.5 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.1 | 0.7 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.1 | 1.6 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.1 | 0.1 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
| 0.1 | 0.1 | GO:0006408 | snRNA export from nucleus(GO:0006408) |
| 0.1 | 3.4 | GO:0015695 | organic cation transport(GO:0015695) |
| 0.1 | 1.2 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.1 | 4.7 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
| 0.1 | 5.0 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
| 0.1 | 0.5 | GO:0002158 | osteoclast proliferation(GO:0002158) |
| 0.1 | 0.4 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.1 | 0.1 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
| 0.1 | 4.5 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
| 0.1 | 0.2 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
| 0.1 | 1.7 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.1 | 0.6 | GO:0097068 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
| 0.1 | 0.7 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
| 0.1 | 2.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.1 | 0.4 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
| 0.1 | 0.7 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.1 | 0.4 | GO:0044266 | multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) |
| 0.1 | 0.5 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.1 | 1.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.1 | 0.5 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
| 0.1 | 1.0 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.1 | 0.5 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
| 0.1 | 0.5 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.1 | 0.8 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.1 | 0.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
| 0.1 | 0.2 | GO:0050968 | thermoception(GO:0050955) detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.1 | 1.5 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
| 0.1 | 1.6 | GO:0031167 | rRNA methylation(GO:0031167) |
| 0.1 | 4.7 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
| 0.1 | 0.6 | GO:0048664 | forebrain anterior/posterior pattern specification(GO:0021797) neuron fate determination(GO:0048664) |
| 0.1 | 0.8 | GO:0071499 | cellular response to laminar fluid shear stress(GO:0071499) |
| 0.1 | 1.5 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
| 0.1 | 0.3 | GO:0031622 | regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) |
| 0.1 | 0.3 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.1 | 0.1 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
| 0.1 | 0.3 | GO:0051572 | negative regulation of histone H3-K36 methylation(GO:0000415) negative regulation of histone H3-K4 methylation(GO:0051572) |
| 0.1 | 3.8 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
| 0.1 | 0.7 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
| 0.1 | 1.1 | GO:0060180 | female mating behavior(GO:0060180) |
| 0.1 | 2.7 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 | 0.6 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
| 0.1 | 0.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.1 | 2.4 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
| 0.1 | 0.2 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
| 0.1 | 0.4 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.1 | 1.3 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.1 | 0.8 | GO:0006226 | dUMP biosynthetic process(GO:0006226) dUMP metabolic process(GO:0046078) |
| 0.1 | 1.9 | GO:0030220 | platelet formation(GO:0030220) |
| 0.1 | 1.0 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.1 | 0.6 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) |
| 0.1 | 3.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.1 | 3.7 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
| 0.1 | 0.2 | GO:0042262 | DNA protection(GO:0042262) |
| 0.1 | 4.6 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.1 | 2.5 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.1 | 0.2 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.1 | 0.4 | GO:0009106 | lipoate metabolic process(GO:0009106) |
| 0.1 | 0.2 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.1 | 0.1 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
| 0.1 | 2.0 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.1 | 0.9 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.1 | 2.5 | GO:0006972 | hyperosmotic response(GO:0006972) |
| 0.1 | 1.3 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
| 0.1 | 0.7 | GO:0048478 | replication fork protection(GO:0048478) |
| 0.1 | 6.0 | GO:0006400 | tRNA modification(GO:0006400) |
| 0.1 | 1.4 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
| 0.1 | 0.4 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.1 | 0.2 | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
| 0.1 | 0.2 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.1 | 0.8 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
| 0.1 | 0.8 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.1 | 0.5 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.1 | 1.4 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.1 | 0.6 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
| 0.1 | 1.9 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.1 | 1.1 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.1 | 0.3 | GO:0006983 | ER overload response(GO:0006983) |
| 0.1 | 0.6 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.1 | 0.3 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
| 0.1 | 2.0 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
| 0.1 | 5.6 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.1 | 0.8 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
| 0.1 | 0.8 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
| 0.1 | 0.4 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 0.1 | 2.3 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.1 | 1.4 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.1 | 0.5 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.1 | 0.3 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 0.1 | 0.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.1 | 3.2 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
| 0.1 | 0.4 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
| 0.1 | 0.7 | GO:0016322 | neuron remodeling(GO:0016322) |
| 0.1 | 0.9 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.1 | 0.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
| 0.1 | 0.5 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.1 | 0.4 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.1 | 0.6 | GO:0045007 | depurination(GO:0045007) |
| 0.1 | 0.3 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 | 0.3 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.1 | 1.4 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.1 | 0.2 | GO:0075528 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.1 | 0.5 | GO:0002118 | aggressive behavior(GO:0002118) |
| 0.1 | 0.1 | GO:1905073 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
| 0.1 | 0.3 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.1 | 2.2 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
| 0.1 | 0.9 | GO:1904869 | regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
| 0.1 | 0.4 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 | 0.3 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
| 0.1 | 0.2 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
| 0.1 | 1.4 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.1 | 0.3 | GO:2001178 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.1 | 0.6 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
| 0.1 | 0.3 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.1 | 3.6 | GO:0034340 | response to type I interferon(GO:0034340) |
| 0.1 | 0.2 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.1 | 0.2 | GO:0032252 | secretory granule localization(GO:0032252) |
| 0.1 | 0.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.1 | 1.7 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
| 0.1 | 1.2 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 | 0.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 0.1 | 0.9 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 0.1 | 0.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.1 | 0.4 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 0.1 | 0.4 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.1 | 0.5 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
| 0.1 | 1.2 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.1 | 0.3 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.1 | 0.2 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.1 | 0.8 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
| 0.1 | 0.7 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
| 0.1 | 0.7 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.1 | 0.3 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
| 0.1 | 1.6 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.1 | 0.3 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.1 | 2.9 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) termination of RNA polymerase I transcription(GO:0006363) |
| 0.1 | 0.2 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
| 0.1 | 0.4 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.1 | 1.0 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.1 | 1.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 | 0.5 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
| 0.1 | 1.4 | GO:0007141 | male meiosis I(GO:0007141) |
| 0.1 | 0.4 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
| 0.1 | 0.5 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 | 0.5 | GO:0015889 | cobalamin transport(GO:0015889) |
| 0.1 | 0.5 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
| 0.1 | 0.4 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.1 | 0.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 | 0.1 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
| 0.1 | 0.3 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.1 | 0.3 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.1 | 0.3 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.1 | 0.3 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.1 | 2.9 | GO:0045123 | cellular extravasation(GO:0045123) |
| 0.1 | 0.3 | GO:0002326 | B cell lineage commitment(GO:0002326) |
| 0.1 | 1.1 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 | 2.8 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
| 0.1 | 0.4 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.1 | 1.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.1 | 0.2 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.1 | 2.3 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
| 0.1 | 0.5 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
| 0.1 | 0.3 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
| 0.1 | 0.1 | GO:2000705 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.1 | 7.3 | GO:0006415 | translational termination(GO:0006415) |
| 0.1 | 0.3 | GO:1902869 | regulation of amacrine cell differentiation(GO:1902869) |
| 0.1 | 0.4 | GO:0006857 | oligopeptide transport(GO:0006857) |
| 0.1 | 13.2 | GO:0042254 | ribosome biogenesis(GO:0042254) |
| 0.1 | 0.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.1 | 0.6 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.1 | 0.9 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
| 0.1 | 1.5 | GO:0051450 | myoblast proliferation(GO:0051450) |
| 0.1 | 0.3 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
| 0.1 | 0.7 | GO:0046697 | decidualization(GO:0046697) |
| 0.1 | 0.6 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.1 | 1.9 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
| 0.1 | 0.1 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
| 0.1 | 0.5 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.1 | 1.6 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
| 0.1 | 0.1 | GO:0051900 | regulation of mitochondrial depolarization(GO:0051900) |
| 0.1 | 0.8 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.1 | 0.2 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
| 0.1 | 0.4 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.1 | 0.2 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
| 0.1 | 0.2 | GO:0051414 | response to cortisol(GO:0051414) |
| 0.1 | 0.1 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
| 0.1 | 1.0 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
| 0.1 | 0.4 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.1 | 0.8 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.1 | 0.6 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
| 0.1 | 5.0 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 | 3.8 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.1 | 0.3 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
| 0.1 | 0.4 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 0.1 | 1.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.1 | 0.5 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.1 | 0.6 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 | 0.5 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.1 | 2.4 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
| 0.1 | 0.2 | GO:0007402 | ganglion mother cell fate determination(GO:0007402) stem cell fate determination(GO:0048867) |
| 0.1 | 0.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
| 0.1 | 0.2 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.1 | 0.4 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.1 | 0.2 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 0.1 | 0.7 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
| 0.1 | 1.4 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.1 | 1.0 | GO:0033572 | transferrin transport(GO:0033572) |
| 0.1 | 0.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 | 0.4 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.1 | 0.2 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
| 0.1 | 0.6 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
| 0.1 | 0.8 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.1 | 0.2 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
| 0.1 | 0.3 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.1 | 0.2 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.1 | 0.1 | GO:0043455 | regulation of secondary metabolic process(GO:0043455) |
| 0.0 | 1.3 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.0 | 0.1 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
| 0.0 | 0.3 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.0 | 4.6 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
| 0.0 | 0.4 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.0 | 0.3 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.0 | 0.3 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.0 | 0.5 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.0 | 0.1 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) |
| 0.0 | 1.5 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.0 | 1.0 | GO:0090382 | phagosome maturation(GO:0090382) |
| 0.0 | 0.2 | GO:0043366 | beta selection(GO:0043366) |
| 0.0 | 0.1 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.0 | 0.4 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.0 | 3.3 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
| 0.0 | 0.6 | GO:0001782 | B cell homeostasis(GO:0001782) |
| 0.0 | 0.5 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 0.0 | 0.1 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.0 | 1.6 | GO:0030818 | negative regulation of cAMP biosynthetic process(GO:0030818) |
| 0.0 | 0.6 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.0 | 3.8 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.0 | 1.0 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
| 0.0 | 1.7 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 0.0 | 0.4 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.0 | 0.4 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.0 | 0.8 | GO:1904356 | regulation of telomere maintenance via telomere lengthening(GO:1904356) |
| 0.0 | 0.5 | GO:0015816 | glycine transport(GO:0015816) |
| 0.0 | 1.0 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.0 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
| 0.0 | 1.0 | GO:0042220 | response to cocaine(GO:0042220) |
| 0.0 | 1.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 | 0.3 | GO:0046541 | saliva secretion(GO:0046541) |
| 0.0 | 0.4 | GO:0060124 | regulation of growth hormone secretion(GO:0060123) positive regulation of growth hormone secretion(GO:0060124) |
| 0.0 | 0.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.0 | 2.3 | GO:0048477 | oogenesis(GO:0048477) |
| 0.0 | 0.3 | GO:0032098 | regulation of appetite(GO:0032098) |
| 0.0 | 0.3 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.0 | 0.1 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
| 0.0 | 0.1 | GO:0060437 | lung growth(GO:0060437) |
| 0.0 | 0.1 | GO:0032571 | response to vitamin K(GO:0032571) |
| 0.0 | 0.2 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.0 | 0.3 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
| 0.0 | 0.9 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
| 0.0 | 1.2 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.0 | 0.7 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
| 0.0 | 0.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 | 0.8 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
| 0.0 | 0.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.0 | 0.2 | GO:0030241 | skeletal muscle thin filament assembly(GO:0030240) skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.0 | 0.2 | GO:1904350 | regulation of protein catabolic process in the vacuole(GO:1904350) positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.0 | 0.2 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.0 | 1.2 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.0 | 0.4 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.0 | 1.8 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
| 0.0 | 1.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.0 | 3.6 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.0 | 2.7 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.0 | 0.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 | 0.2 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
| 0.0 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.0 | 0.8 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.0 | 1.2 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.0 | 3.4 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
| 0.0 | 1.1 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.0 | 0.7 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.0 | 0.5 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.0 | 0.2 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
| 0.0 | 3.3 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
| 0.0 | 0.3 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.0 | 0.5 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 | 0.3 | GO:0002181 | cytoplasmic translation(GO:0002181) |
| 0.0 | 0.2 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 0.0 | 0.3 | GO:0045116 | mitotic DNA replication checkpoint(GO:0033314) protein neddylation(GO:0045116) |
| 0.0 | 0.2 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.0 | 0.1 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
| 0.0 | 0.6 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.0 | 1.5 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.0 | 0.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.0 | 0.3 | GO:0042723 | thiamine-containing compound metabolic process(GO:0042723) |
| 0.0 | 0.1 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.0 | 1.2 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.0 | 0.5 | GO:0006568 | tryptophan metabolic process(GO:0006568) |
| 0.0 | 0.3 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
| 0.0 | 0.6 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.0 | 0.1 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
| 0.0 | 2.6 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) |
| 0.0 | 0.2 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.0 | 0.5 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.0 | 0.4 | GO:0001825 | blastocyst formation(GO:0001825) |
| 0.0 | 0.5 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.0 | 0.2 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.0 | 0.7 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.0 | 0.2 | GO:0046465 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 0.0 | 0.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.0 | 1.1 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 0.0 | 0.5 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
| 0.0 | 0.5 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
| 0.0 | 0.2 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.0 | 0.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.0 | 0.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.0 | 0.7 | GO:0060325 | face morphogenesis(GO:0060325) |
| 0.0 | 0.1 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 0.0 | 0.4 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
| 0.0 | 2.3 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
| 0.0 | 0.4 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.0 | 0.2 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.0 | 0.4 | GO:0042737 | drug catabolic process(GO:0042737) |
| 0.0 | 0.3 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
| 0.0 | 0.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.0 | 0.1 | GO:1900825 | regulation of membrane depolarization during action potential(GO:0098902) regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
| 0.0 | 0.1 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.0 | 0.3 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
| 0.0 | 0.1 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
| 0.0 | 0.2 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.0 | 1.5 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.0 | 1.0 | GO:0097484 | dendrite extension(GO:0097484) |
| 0.0 | 0.4 | GO:0006067 | ethanol metabolic process(GO:0006067) |
| 0.0 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
| 0.0 | 0.3 | GO:0010991 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.0 | 0.2 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.0 | 0.1 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.0 | 1.5 | GO:0001942 | hair follicle development(GO:0001942) |
| 0.0 | 0.4 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
| 0.0 | 0.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.0 | 0.5 | GO:0034776 | response to histamine(GO:0034776) |
| 0.0 | 0.2 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.0 | 0.2 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
| 0.0 | 0.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.0 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.0 | 0.3 | GO:0035666 | TRIF-dependent toll-like receptor signaling pathway(GO:0035666) |
| 0.0 | 0.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.0 | 0.0 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.0 | 0.3 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
| 0.0 | 0.4 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.0 | 0.2 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.0 | 0.9 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.0 | 0.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.0 | 0.1 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
| 0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.0 | 0.4 | GO:0032438 | melanosome organization(GO:0032438) |
| 0.0 | 1.3 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
| 0.0 | 0.1 | GO:0099551 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 0.0 | 0.2 | GO:1990118 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.0 | 0.3 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.0 | 0.1 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 0.0 | 1.9 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.0 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
| 0.0 | 0.1 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
| 0.0 | 0.1 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.0 | 0.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
| 0.0 | 0.0 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.0 | 0.2 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.0 | 0.3 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
| 0.0 | 0.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.0 | 0.2 | GO:0007520 | myoblast fusion(GO:0007520) |
| 0.0 | 0.3 | GO:0046039 | GTP metabolic process(GO:0046039) |
| 0.0 | 0.6 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 | 0.1 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.0 | 0.1 | GO:1904245 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.0 | 0.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.0 | 0.1 | GO:0007512 | adult heart development(GO:0007512) |
| 0.0 | 0.9 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.0 | 0.1 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
| 0.0 | 0.1 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.0 | 0.2 | GO:1902624 | positive regulation of neutrophil chemotaxis(GO:0090023) positive regulation of neutrophil migration(GO:1902624) |
| 0.0 | 0.4 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.0 | 0.1 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.0 | 1.2 | GO:0006401 | RNA catabolic process(GO:0006401) |
| 0.0 | 2.8 | GO:0050658 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) |
| 0.0 | 0.2 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
| 0.0 | 0.0 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.0 | 0.1 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
| 0.0 | 0.2 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
| 0.0 | 0.0 | GO:0018874 | benzoate metabolic process(GO:0018874) |
| 0.0 | 0.1 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
| 0.0 | 0.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.0 | 0.0 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.0 | 0.1 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
| 0.0 | 0.0 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 0.0 | 0.5 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
| 0.0 | 0.2 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
| 0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.0 | 0.0 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 0.0 | 0.0 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) constitutive secretory pathway(GO:0045054) |
| 0.0 | 0.1 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 0.0 | 0.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
| 0.0 | 0.0 | GO:2000849 | glucocorticoid secretion(GO:0035933) regulation of glucocorticoid secretion(GO:2000849) |
| 0.0 | 0.1 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.0 | 0.2 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
| 0.0 | 0.2 | GO:0010447 | response to acidic pH(GO:0010447) |
| 0.0 | 0.4 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
| 0.0 | 0.0 | GO:0042350 | GDP-L-fucose biosynthetic process(GO:0042350) |
| 0.0 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.0 | 0.1 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
| 0.0 | 0.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.0 | 0.1 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.0 | 0.1 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
| 0.0 | 1.0 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.0 | 0.1 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.7 | 24.0 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 1.8 | 5.5 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
| 1.4 | 10.9 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 1.4 | 6.8 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 1.3 | 7.7 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 1.2 | 4.6 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
| 1.1 | 12.8 | GO:0005642 | annulate lamellae(GO:0005642) |
| 1.0 | 3.8 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.9 | 4.7 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.9 | 4.5 | GO:1905202 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 0.9 | 4.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.9 | 5.2 | GO:0090661 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
| 0.8 | 6.4 | GO:0032010 | phagolysosome(GO:0032010) |
| 0.8 | 2.3 | GO:0030689 | Noc complex(GO:0030689) |
| 0.7 | 5.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.7 | 47.6 | GO:0015030 | Cajal body(GO:0015030) |
| 0.7 | 2.7 | GO:0070985 | TFIIK complex(GO:0070985) |
| 0.7 | 2.6 | GO:0001652 | granular component(GO:0001652) |
| 0.6 | 11.6 | GO:0034709 | methylosome(GO:0034709) |
| 0.6 | 1.9 | GO:0097447 | dendritic tree(GO:0097447) |
| 0.6 | 1.9 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.6 | 0.6 | GO:0043260 | laminin-11 complex(GO:0043260) |
| 0.6 | 3.4 | GO:1990037 | Lewy body core(GO:1990037) |
| 0.6 | 2.8 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.6 | 4.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.6 | 3.4 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.6 | 3.9 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.5 | 2.6 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.5 | 1.0 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 0.5 | 4.9 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 0.5 | 3.9 | GO:0031415 | NatA complex(GO:0031415) |
| 0.5 | 2.8 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.5 | 5.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.4 | 0.8 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 0.4 | 5.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.4 | 1.2 | GO:0097413 | Lewy body(GO:0097413) |
| 0.4 | 3.2 | GO:0072487 | MSL complex(GO:0072487) |
| 0.4 | 2.0 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.4 | 6.8 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.4 | 3.1 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.4 | 7.2 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.4 | 1.9 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 0.4 | 2.2 | GO:0089701 | U2AF(GO:0089701) |
| 0.4 | 6.7 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.4 | 1.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
| 0.4 | 1.8 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.4 | 2.1 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.3 | 3.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.3 | 1.0 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 0.3 | 2.6 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.3 | 2.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.3 | 14.7 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.3 | 17.9 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.3 | 5.4 | GO:0032059 | bleb(GO:0032059) |
| 0.3 | 4.8 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.3 | 2.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.3 | 5.3 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.3 | 1.5 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.3 | 8.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.3 | 2.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.3 | 2.4 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.3 | 1.5 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 0.3 | 6.9 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.3 | 4.0 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.3 | 5.7 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
| 0.3 | 1.6 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 0.3 | 2.3 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.2 | 2.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.2 | 2.2 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.2 | 3.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.2 | 2.9 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.2 | 2.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.2 | 2.1 | GO:0001939 | female pronucleus(GO:0001939) |
| 0.2 | 1.6 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.2 | 1.8 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.2 | 1.8 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
| 0.2 | 1.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.2 | 1.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.2 | 0.2 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.2 | 5.4 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.2 | 0.9 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
| 0.2 | 1.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.2 | 0.8 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.2 | 3.0 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.2 | 0.8 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.2 | 2.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.2 | 6.6 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
| 0.2 | 1.4 | GO:0033503 | HULC complex(GO:0033503) |
| 0.2 | 1.0 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
| 0.2 | 1.2 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.2 | 4.4 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.2 | 1.6 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
| 0.2 | 0.8 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.2 | 1.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.2 | 1.2 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.2 | 0.8 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.2 | 0.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.2 | 0.6 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
| 0.2 | 0.9 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.2 | 0.4 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
| 0.2 | 2.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
| 0.2 | 0.5 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 0.2 | 3.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.2 | 4.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.2 | 1.7 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.2 | 2.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.2 | 1.0 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.2 | 0.5 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.2 | 3.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.2 | 0.8 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.2 | 65.4 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
| 0.2 | 1.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.2 | 2.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.2 | 0.6 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.2 | 0.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.2 | 0.6 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.2 | 1.4 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.1 | 3.1 | GO:0005682 | U5 snRNP(GO:0005682) |
| 0.1 | 1.2 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.1 | 1.1 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 0.1 | 0.4 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
| 0.1 | 0.7 | GO:0070826 | paraferritin complex(GO:0070826) |
| 0.1 | 0.8 | GO:0000243 | commitment complex(GO:0000243) |
| 0.1 | 0.7 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.1 | 1.5 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.1 | 4.2 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.1 | 0.5 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.1 | 1.7 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.1 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.1 | 0.5 | GO:0071664 | beta-catenin-TCF7L2 complex(GO:0070369) catenin-TCF7L2 complex(GO:0071664) |
| 0.1 | 0.5 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 0.1 | 0.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 0.1 | 0.6 | GO:0000938 | GARP complex(GO:0000938) |
| 0.1 | 0.9 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.1 | 0.4 | GO:0098855 | HCN channel complex(GO:0098855) |
| 0.1 | 1.5 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.1 | 0.4 | GO:0097450 | astrocyte end-foot(GO:0097450) |
| 0.1 | 0.6 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.1 | 1.0 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.1 | 0.3 | GO:0097422 | tubular endosome(GO:0097422) |
| 0.1 | 2.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.1 | 0.2 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
| 0.1 | 0.1 | GO:0005608 | laminin-3 complex(GO:0005608) |
| 0.1 | 0.6 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.1 | 0.3 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.1 | 0.3 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.1 | 0.3 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 0.1 | 0.3 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
| 0.1 | 0.3 | GO:0001534 | radial spoke(GO:0001534) |
| 0.1 | 2.4 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.1 | 0.8 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.1 | 1.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.1 | 0.3 | GO:0016938 | kinesin I complex(GO:0016938) |
| 0.1 | 3.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.1 | 5.2 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.1 | 0.4 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.1 | 0.4 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.1 | 0.2 | GO:0005638 | lamin filament(GO:0005638) |
| 0.1 | 2.3 | GO:0005922 | connexon complex(GO:0005922) |
| 0.1 | 6.7 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.1 | 1.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.1 | 1.9 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.1 | 1.5 | GO:0071437 | invadopodium(GO:0071437) |
| 0.1 | 2.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.1 | 1.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.1 | 6.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.1 | 7.0 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.1 | 0.6 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.1 | 1.2 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.1 | 0.3 | GO:0044308 | axonal spine(GO:0044308) |
| 0.1 | 0.8 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.1 | 0.6 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.1 | 0.4 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
| 0.1 | 0.7 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.1 | 3.9 | GO:0043034 | costamere(GO:0043034) |
| 0.1 | 10.3 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.1 | 0.9 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.1 | 4.4 | GO:0031970 | organelle envelope lumen(GO:0031970) |
| 0.1 | 1.9 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.1 | 0.2 | GO:0043656 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
| 0.1 | 0.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.1 | 15.9 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.1 | 3.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.1 | 0.8 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.1 | 0.7 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.1 | 0.7 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
| 0.1 | 1.4 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.1 | 1.9 | GO:0042627 | chylomicron(GO:0042627) |
| 0.1 | 1.0 | GO:0001741 | XY body(GO:0001741) |
| 0.1 | 0.8 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.1 | 5.7 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.1 | 0.2 | GO:0043203 | axon hillock(GO:0043203) |
| 0.1 | 0.1 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.1 | 0.4 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
| 0.1 | 0.4 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.1 | 0.4 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
| 0.1 | 8.2 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.1 | 7.4 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.1 | 1.9 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.1 | 0.1 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.1 | 2.0 | GO:0016580 | Sin3 complex(GO:0016580) |
| 0.1 | 0.4 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.1 | 0.3 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 0.1 | 0.7 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.1 | 0.9 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
| 0.1 | 0.3 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.1 | 0.7 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.1 | 6.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.1 | 0.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.1 | 3.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 1.7 | GO:0031091 | platelet alpha granule(GO:0031091) |
| 0.1 | 0.7 | GO:0043219 | lateral loop(GO:0043219) |
| 0.1 | 1.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.1 | 0.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.1 | 0.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.1 | 0.9 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.1 | 0.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.1 | 0.3 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
| 0.1 | 0.9 | GO:0000800 | lateral element(GO:0000800) |
| 0.1 | 0.4 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.1 | 0.5 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.1 | 6.8 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.1 | 0.6 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.1 | 1.9 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
| 0.1 | 17.8 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.0 | 0.5 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.0 | 3.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.0 | 0.3 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.0 | 0.7 | GO:0043596 | nuclear replication fork(GO:0043596) |
| 0.0 | 0.1 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.0 | 0.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.0 | 4.0 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.0 | 0.2 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.0 | 1.6 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.0 | 0.1 | GO:0033011 | perinuclear theca(GO:0033011) |
| 0.0 | 0.4 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.0 | 6.3 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
| 0.0 | 0.7 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.0 | 0.6 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.0 | 0.3 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.0 | 0.4 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.0 | 1.3 | GO:0005844 | polysome(GO:0005844) |
| 0.0 | 2.1 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.0 | 0.2 | GO:0070938 | contractile ring(GO:0070938) |
| 0.0 | 0.5 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.0 | 0.2 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.0 | 0.4 | GO:0048500 | signal recognition particle(GO:0048500) |
| 0.0 | 0.3 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.0 | 0.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 0.0 | 0.1 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.0 | 0.5 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.0 | 0.7 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.0 | 1.9 | GO:0000792 | heterochromatin(GO:0000792) |
| 0.0 | 0.8 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.0 | 1.0 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.0 | 0.1 | GO:0060187 | cell pole(GO:0060187) |
| 0.0 | 0.5 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.0 | 14.7 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.0 | 0.1 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
| 0.0 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
| 0.0 | 0.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.0 | 0.2 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.0 | 0.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.0 | 0.3 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.0 | 0.8 | GO:0005865 | striated muscle thin filament(GO:0005865) |
| 0.0 | 4.1 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.0 | 1.1 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.0 | 2.9 | GO:0005635 | nuclear envelope(GO:0005635) |
| 0.0 | 2.9 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.0 | 0.1 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 0.0 | 0.4 | GO:0044447 | axoneme part(GO:0044447) |
| 0.0 | 0.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.0 | 0.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.0 | 0.4 | GO:0032156 | septin cytoskeleton(GO:0032156) |
| 0.0 | 0.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.0 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.0 | 1.1 | GO:0005776 | autophagosome(GO:0005776) |
| 0.0 | 0.6 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.0 | 0.2 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.0 | 0.1 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.0 | 0.1 | GO:0005579 | membrane attack complex(GO:0005579) |
| 0.0 | 0.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.0 | 0.5 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.0 | 0.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.0 | 13.4 | GO:0005730 | nucleolus(GO:0005730) |
| 0.0 | 0.3 | GO:0030057 | desmosome(GO:0030057) |
| 0.0 | 2.7 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.0 | 1.5 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.0 | 0.1 | GO:0000801 | central element(GO:0000801) |
| 0.0 | 0.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.0 | 0.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.0 | 0.1 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.0 | 0.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 14.8 | 44.5 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 7.1 | 28.5 | GO:0005292 | high-affinity basic amino acid transmembrane transporter activity(GO:0005287) high-affinity arginine transmembrane transporter activity(GO:0005289) high-affinity lysine transmembrane transporter activity(GO:0005292) |
| 3.7 | 18.5 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 3.2 | 9.5 | GO:0070362 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial heavy strand promoter sense binding(GO:0070364) |
| 3.1 | 55.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 2.4 | 7.3 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 2.3 | 6.8 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 2.1 | 10.4 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
| 1.8 | 5.5 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
| 1.8 | 5.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 1.3 | 3.8 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
| 1.2 | 7.4 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 1.2 | 3.6 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
| 1.1 | 3.3 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 1.1 | 3.2 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
| 1.1 | 7.5 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 1.1 | 3.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 1.0 | 5.2 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
| 1.0 | 9.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 1.0 | 4.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 1.0 | 3.0 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 1.0 | 3.8 | GO:0035501 | MH1 domain binding(GO:0035501) |
| 1.0 | 5.7 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.9 | 8.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.9 | 2.8 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
| 0.9 | 4.6 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
| 0.9 | 4.5 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
| 0.8 | 5.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 0.8 | 25.9 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.8 | 2.3 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.8 | 2.3 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.8 | 3.1 | GO:0004793 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
| 0.8 | 3.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 0.8 | 2.3 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 0.8 | 6.9 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
| 0.8 | 3.8 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.8 | 3.0 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
| 0.7 | 4.5 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 0.7 | 5.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 0.7 | 3.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.7 | 2.6 | GO:0008513 | secondary active organic cation transmembrane transporter activity(GO:0008513) |
| 0.7 | 3.3 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
| 0.6 | 3.2 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
| 0.6 | 2.5 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 0.6 | 1.9 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
| 0.6 | 3.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
| 0.6 | 1.9 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
| 0.6 | 2.5 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
| 0.6 | 6.9 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.6 | 2.4 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.6 | 1.8 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.6 | 6.5 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.6 | 3.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
| 0.6 | 5.2 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.6 | 2.9 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.6 | 4.5 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.6 | 1.7 | GO:0000773 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 0.5 | 6.0 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 0.5 | 1.0 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
| 0.5 | 1.6 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
| 0.5 | 0.5 | GO:0035877 | death effector domain binding(GO:0035877) |
| 0.5 | 1.5 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
| 0.5 | 3.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.5 | 6.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.5 | 1.9 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.5 | 4.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.5 | 1.4 | GO:0008478 | pyridoxal kinase activity(GO:0008478) lithium ion binding(GO:0031403) |
| 0.5 | 1.4 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
| 0.5 | 1.8 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
| 0.5 | 4.6 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.5 | 1.8 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.5 | 1.4 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.5 | 3.2 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.4 | 1.3 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.4 | 1.8 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.4 | 9.8 | GO:0030515 | snoRNA binding(GO:0030515) |
| 0.4 | 4.4 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
| 0.4 | 1.7 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.4 | 0.4 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
| 0.4 | 1.2 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
| 0.4 | 0.8 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
| 0.4 | 1.6 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.4 | 0.8 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.4 | 2.4 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.4 | 1.2 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.4 | 2.0 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.4 | 1.2 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.4 | 0.8 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
| 0.4 | 2.7 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.4 | 0.4 | GO:0004818 | glutamate-tRNA ligase activity(GO:0004818) |
| 0.4 | 3.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.4 | 3.4 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 0.4 | 0.7 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 0.4 | 1.1 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.4 | 1.5 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
| 0.4 | 1.1 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
| 0.4 | 3.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.4 | 1.1 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.4 | 1.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.4 | 5.3 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.3 | 8.4 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.3 | 0.3 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 0.3 | 1.0 | GO:0005174 | CD40 receptor binding(GO:0005174) |
| 0.3 | 1.7 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 0.3 | 19.4 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.3 | 1.9 | GO:0045569 | TRAIL binding(GO:0045569) |
| 0.3 | 1.9 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.3 | 2.6 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.3 | 4.8 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.3 | 1.0 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
| 0.3 | 0.3 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 0.3 | 6.0 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.3 | 4.7 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.3 | 1.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.3 | 0.9 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 0.3 | 1.2 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
| 0.3 | 1.8 | GO:0042806 | fucose binding(GO:0042806) |
| 0.3 | 2.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.3 | 1.5 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.3 | 1.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.3 | 12.1 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
| 0.3 | 0.9 | GO:0000035 | acyl binding(GO:0000035) |
| 0.3 | 2.9 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.3 | 4.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.3 | 2.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.3 | 2.8 | GO:0015288 | porin activity(GO:0015288) |
| 0.3 | 5.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.3 | 1.1 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 0.3 | 0.8 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 0.3 | 0.8 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.3 | 0.3 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.3 | 1.3 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 0.3 | 1.6 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.3 | 2.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.3 | 4.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.3 | 0.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 0.3 | 3.1 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.3 | 1.3 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.3 | 0.8 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
| 0.3 | 3.8 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.3 | 12.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.3 | 1.8 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.2 | 0.7 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
| 0.2 | 3.0 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.2 | 0.5 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
| 0.2 | 1.0 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.2 | 1.0 | GO:0032408 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
| 0.2 | 3.8 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.2 | 0.7 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 0.2 | 0.7 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
| 0.2 | 4.2 | GO:0048185 | activin binding(GO:0048185) |
| 0.2 | 0.2 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) |
| 0.2 | 1.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.2 | 1.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.2 | 3.4 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.2 | 0.9 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.2 | 0.9 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 0.2 | 0.2 | GO:0033677 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) DNA/RNA helicase activity(GO:0033677) |
| 0.2 | 0.4 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
| 0.2 | 1.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.2 | 4.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.2 | 1.3 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.2 | 2.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.2 | 1.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.2 | 0.6 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
| 0.2 | 0.6 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity(GO:0043337) |
| 0.2 | 1.8 | GO:0043426 | MRF binding(GO:0043426) |
| 0.2 | 0.6 | GO:0001147 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
| 0.2 | 5.0 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
| 0.2 | 3.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.2 | 1.6 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.2 | 2.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.2 | 2.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.2 | 0.8 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.2 | 8.7 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.2 | 6.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.2 | 1.0 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.2 | 2.5 | GO:0001851 | complement component C3b binding(GO:0001851) |
| 0.2 | 0.9 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.2 | 3.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.2 | 0.9 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.2 | 2.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.2 | 0.7 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.2 | 0.7 | GO:0034584 | piRNA binding(GO:0034584) |
| 0.2 | 10.0 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.2 | 1.1 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 0.2 | 2.3 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 0.2 | 0.9 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
| 0.2 | 0.5 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.2 | 1.9 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
| 0.2 | 0.7 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.2 | 2.4 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.2 | 5.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.2 | 0.5 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.2 | 1.8 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.2 | 0.7 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
| 0.2 | 1.0 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.2 | 0.5 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 0.2 | 0.7 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
| 0.2 | 1.9 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
| 0.2 | 0.6 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 0.2 | 2.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.2 | 1.0 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 0.2 | 0.5 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 0.2 | 0.6 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
| 0.2 | 0.9 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.2 | 0.8 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
| 0.2 | 1.5 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.2 | 1.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.2 | 1.4 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
| 0.2 | 5.7 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.2 | 1.8 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
| 0.2 | 0.6 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) |
| 0.2 | 2.6 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.2 | 2.9 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.2 | 0.6 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) enone reductase activity(GO:0035671) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.1 | 0.9 | GO:0050610 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
| 0.1 | 0.6 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.1 | 1.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.1 | 1.2 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.1 | 1.6 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.1 | 1.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.1 | 1.4 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.1 | 0.4 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.1 | 2.2 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 0.1 | 2.5 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.1 | 0.5 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 0.1 | 21.0 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.1 | 1.5 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.1 | 0.5 | GO:0004802 | transketolase activity(GO:0004802) |
| 0.1 | 0.8 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.1 | 0.4 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.1 | 1.1 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.1 | 0.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.1 | 5.9 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
| 0.1 | 1.6 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.1 | 0.6 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
| 0.1 | 0.5 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.1 | 3.5 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.1 | 0.7 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.1 | 3.5 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
| 0.1 | 0.6 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
| 0.1 | 0.5 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.1 | 0.5 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 0.1 | 1.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.1 | 3.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.1 | 2.7 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.1 | 5.2 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.1 | 0.5 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.1 | 2.5 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.1 | 0.5 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.1 | 0.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.1 | 0.6 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 0.1 | 2.2 | GO:0004521 | endoribonuclease activity(GO:0004521) |
| 0.1 | 0.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.1 | 0.3 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 0.1 | 1.0 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.1 | 0.5 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 0.1 | 5.0 | GO:0000049 | tRNA binding(GO:0000049) |
| 0.1 | 0.8 | GO:0071253 | connexin binding(GO:0071253) |
| 0.1 | 5.3 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.1 | 0.3 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
| 0.1 | 9.5 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
| 0.1 | 3.4 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.1 | 0.7 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.1 | 1.3 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.1 | 1.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.1 | 1.1 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
| 0.1 | 1.7 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 0.1 | 0.2 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 0.1 | 0.2 | GO:0030614 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) |
| 0.1 | 2.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.1 | 1.1 | GO:0036122 | BMP binding(GO:0036122) |
| 0.1 | 0.3 | GO:0015193 | L-alanine transmembrane transporter activity(GO:0015180) L-proline transmembrane transporter activity(GO:0015193) alanine transmembrane transporter activity(GO:0022858) |
| 0.1 | 2.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.1 | 0.2 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
| 0.1 | 0.3 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 0.1 | 0.6 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.1 | 1.0 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.1 | 0.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.1 | 0.5 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
| 0.1 | 0.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.1 | 5.3 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
| 0.1 | 1.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.1 | 6.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 1.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.1 | 3.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.1 | 3.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.1 | 0.6 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.1 | 0.3 | GO:0016731 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
| 0.1 | 2.0 | GO:0004659 | prenyltransferase activity(GO:0004659) |
| 0.1 | 0.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.1 | 0.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.1 | 0.4 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 0.1 | 0.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.1 | 1.3 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.1 | 0.4 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 0.1 | 0.4 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.1 | 0.4 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
| 0.1 | 1.7 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
| 0.1 | 0.7 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.1 | 0.7 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.1 | 1.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.1 | 0.5 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.1 | 4.0 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.1 | 8.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.1 | 0.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.1 | 0.7 | GO:0019956 | chemokine binding(GO:0019956) |
| 0.1 | 0.5 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.1 | 0.3 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.1 | 0.9 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.1 | 0.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
| 0.1 | 0.6 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.1 | 0.2 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
| 0.1 | 1.7 | GO:0031005 | filamin binding(GO:0031005) |
| 0.1 | 1.4 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.1 | 0.2 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 0.1 | 8.3 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
| 0.1 | 0.2 | GO:0033149 | FFAT motif binding(GO:0033149) |
| 0.1 | 0.2 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
| 0.1 | 0.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.1 | 1.8 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.1 | 3.9 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.1 | 1.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.1 | 0.3 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.1 | 1.0 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
| 0.1 | 0.7 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
| 0.1 | 1.3 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.1 | 3.0 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.1 | 0.3 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
| 0.1 | 0.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.1 | 1.6 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
| 0.1 | 3.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 0.1 | 0.8 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.1 | 0.2 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
| 0.1 | 1.7 | GO:0030553 | cGMP binding(GO:0030553) |
| 0.1 | 1.4 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.1 | 0.8 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
| 0.1 | 0.2 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
| 0.1 | 2.3 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.1 | 0.3 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
| 0.1 | 7.9 | GO:0051087 | chaperone binding(GO:0051087) |
| 0.1 | 0.2 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.1 | 1.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.1 | 0.5 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 0.1 | 1.2 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.1 | 5.7 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.1 | 0.3 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.1 | 8.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.1 | 0.6 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.1 | 0.2 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
| 0.1 | 0.4 | GO:0070513 | death domain binding(GO:0070513) |
| 0.1 | 0.1 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
| 0.1 | 1.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.1 | 1.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.1 | 11.6 | GO:0001047 | core promoter binding(GO:0001047) |
| 0.1 | 1.0 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
| 0.1 | 0.2 | GO:0050693 | LBD domain binding(GO:0050693) |
| 0.1 | 0.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 0.1 | 9.5 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
| 0.1 | 1.6 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.1 | 0.6 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 0.1 | 0.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.1 | 0.2 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
| 0.1 | 0.2 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
| 0.1 | 0.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.1 | 0.2 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
| 0.1 | 0.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.1 | 0.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.1 | 0.3 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
| 0.1 | 0.9 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.1 | 1.0 | GO:0001848 | complement binding(GO:0001848) |
| 0.1 | 1.0 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.1 | 0.9 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
| 0.1 | 1.6 | GO:0043022 | ribosome binding(GO:0043022) |
| 0.0 | 1.8 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.0 | 0.1 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
| 0.0 | 0.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
| 0.0 | 0.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.0 | 0.3 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 0.0 | 0.3 | GO:0031705 | bombesin receptor binding(GO:0031705) |
| 0.0 | 0.3 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.0 | 0.3 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.0 | 0.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 0.0 | 2.3 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.0 | 0.5 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.0 | 0.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.0 | 0.7 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.0 | 0.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.0 | 1.2 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.0 | 1.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.0 | 1.4 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.0 | 1.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.0 | 1.0 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.0 | 0.2 | GO:0015207 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 0.0 | 0.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
| 0.0 | 0.3 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.0 | 60.3 | GO:0003723 | RNA binding(GO:0003723) |
| 0.0 | 0.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.0 | 1.8 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 0.0 | 1.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.0 | 0.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.0 | 0.4 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.0 | 0.3 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.0 | 0.4 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.0 | 0.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.0 | 0.4 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
| 0.0 | 1.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.0 | 0.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.0 | 0.1 | GO:0004040 | amidase activity(GO:0004040) |
| 0.0 | 0.8 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.0 | 0.1 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
| 0.0 | 0.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
| 0.0 | 0.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.0 | 13.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.0 | 0.2 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
| 0.0 | 0.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 0.0 | 0.1 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
| 0.0 | 0.1 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 0.0 | 0.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.0 | 0.7 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.0 | 1.7 | GO:0005507 | copper ion binding(GO:0005507) |
| 0.0 | 0.2 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
| 0.0 | 0.2 | GO:0097617 | annealing activity(GO:0097617) |
| 0.0 | 1.5 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.0 | 0.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.0 | 0.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 0.0 | 0.3 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
| 0.0 | 0.1 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
| 0.0 | 0.2 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
| 0.0 | 2.0 | GO:0005518 | collagen binding(GO:0005518) |
| 0.0 | 0.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.0 | 0.6 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.0 | 0.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.0 | 0.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.0 | 0.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.0 | 0.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.0 | 0.4 | GO:0019864 | IgG binding(GO:0019864) |
| 0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.0 | 0.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.0 | 0.1 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
| 0.0 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.0 | 0.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.0 | 0.3 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.0 | 0.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.0 | 1.8 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.0 | 0.6 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.0 | 0.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.0 | 0.1 | GO:0030172 | troponin C binding(GO:0030172) |
| 0.0 | 0.2 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
| 0.0 | 0.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.0 | 1.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.0 | 0.2 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.0 | 0.0 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
| 0.0 | 0.1 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
| 0.0 | 0.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.0 | 0.5 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
| 0.0 | 0.2 | GO:0043236 | laminin binding(GO:0043236) |
| 0.0 | 0.1 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
| 0.0 | 0.1 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.0 | 0.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.0 | 0.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.0 | 0.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.0 | 0.1 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.0 | 0.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.0 | 0.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.0 | 0.1 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) NAD-dependent protein deacetylase activity(GO:0034979) |
| 0.0 | 1.0 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.0 | 0.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.6 | 3.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.5 | 18.8 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.4 | 1.1 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.3 | 10.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.3 | 12.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.3 | 6.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.3 | 6.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.2 | 2.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.2 | 7.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.2 | 2.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
| 0.2 | 0.6 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.2 | 27.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.2 | 2.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.2 | 4.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.2 | 8.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.2 | 14.2 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.1 | 4.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.1 | 4.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.1 | 3.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.1 | 9.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.1 | 2.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.1 | 11.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.1 | 1.9 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.1 | 2.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.1 | 0.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.1 | 1.9 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.1 | 3.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.1 | 7.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.1 | 4.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.1 | 4.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.1 | 1.6 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
| 0.1 | 1.8 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.1 | 2.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.1 | 0.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.1 | 2.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.1 | 3.7 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.1 | 2.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.1 | 8.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.1 | 7.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.1 | 2.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.1 | 0.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.1 | 2.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.1 | 3.5 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.1 | 2.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.1 | 0.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.1 | 0.5 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.1 | 4.4 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.1 | 4.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.1 | 0.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.1 | 2.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.1 | 0.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.1 | 1.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.1 | 0.6 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.1 | 1.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.1 | 0.7 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.1 | 2.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.0 | 2.9 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.0 | 0.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.0 | 4.0 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.0 | 1.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.0 | 1.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.0 | 0.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.0 | 0.6 | PID FGF PATHWAY | FGF signaling pathway |
| 0.0 | 0.4 | PID MYC PATHWAY | C-MYC pathway |
| 0.0 | 0.7 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.0 | 0.6 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.0 | 0.2 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.0 | 0.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.0 | 1.0 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.0 | 0.2 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
| 0.0 | 1.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.0 | 0.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.0 | 0.3 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.0 | 0.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.0 | 0.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.0 | 0.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.0 | 5.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 1.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 0.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
| 0.0 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.0 | 0.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.0 | 0.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.0 | 0.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.0 | 0.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.0 | 0.3 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.0 | 0.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.0 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.0 | 0.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.0 | 2.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.8 | 55.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.7 | 68.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.6 | 17.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.6 | 30.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.6 | 1.8 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.5 | 11.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.5 | 16.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.5 | 4.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.4 | 2.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.4 | 7.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.3 | 4.5 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.3 | 8.4 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.3 | 8.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.3 | 20.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.3 | 9.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.3 | 9.6 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.3 | 1.2 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
| 0.3 | 13.7 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 0.3 | 9.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.3 | 19.9 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
| 0.3 | 20.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.3 | 2.5 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.3 | 4.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.3 | 5.4 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
| 0.2 | 6.2 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.2 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.2 | 1.2 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
| 0.2 | 8.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.2 | 2.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.2 | 2.1 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.2 | 3.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.2 | 9.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.2 | 1.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.2 | 6.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.2 | 4.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.2 | 2.6 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
| 0.2 | 9.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.2 | 8.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.2 | 1.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.2 | 1.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.2 | 7.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.2 | 3.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.2 | 21.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.2 | 3.5 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.2 | 4.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.2 | 3.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.1 | 2.2 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
| 0.1 | 2.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.1 | 1.5 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
| 0.1 | 2.8 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.1 | 6.4 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
| 0.1 | 3.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.1 | 1.5 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.1 | 2.0 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.1 | 3.4 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
| 0.1 | 7.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.1 | 2.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.1 | 2.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.1 | 2.7 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.1 | 4.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.1 | 1.6 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 0.1 | 7.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.1 | 4.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.1 | 3.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.1 | 2.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.1 | 3.1 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.1 | 0.1 | REACTOME INSULIN RECEPTOR SIGNALLING CASCADE | Genes involved in Insulin receptor signalling cascade |
| 0.1 | 1.5 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
| 0.1 | 0.8 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
| 0.1 | 0.8 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 0.1 | 1.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.1 | 1.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.1 | 2.3 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.1 | 5.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.1 | 1.2 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.1 | 0.8 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.1 | 1.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.1 | 2.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.1 | 1.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.1 | 0.2 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
| 0.1 | 2.2 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
| 0.1 | 15.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.1 | 4.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.1 | 0.9 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.1 | 1.0 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.1 | 1.1 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.1 | 1.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.1 | 2.5 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
| 0.1 | 1.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.1 | 1.5 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.1 | 0.9 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.1 | 0.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.1 | 2.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.1 | 1.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.1 | 1.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.1 | 0.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.1 | 0.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.0 | 0.7 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.0 | 3.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.0 | 1.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.0 | 2.0 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.0 | 0.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.0 | 0.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.0 | 1.1 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.0 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.0 | 0.6 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.0 | 0.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.0 | 0.5 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
| 0.0 | 4.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.0 | 1.7 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
| 0.0 | 3.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.0 | 0.6 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.0 | 0.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.0 | 0.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.0 | 6.7 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
| 0.0 | 0.8 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.0 | 0.4 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
| 0.0 | 0.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.0 | 0.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.0 | 0.6 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.0 | 0.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
| 0.0 | 2.5 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.0 | 0.3 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.0 | 0.6 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
| 0.0 | 1.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.0 | 2.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.0 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
| 0.0 | 0.5 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.0 | 0.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.0 | 0.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.0 | 0.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.0 | 0.6 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
| 0.0 | 0.5 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.0 | 0.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.0 | 0.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 0.0 | 0.8 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
| 0.0 | 1.0 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
| 0.0 | 0.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.0 | 0.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.0 | 0.9 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
| 0.0 | 1.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.0 | 0.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 0.0 | 0.4 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 0.0 | 0.3 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
| 0.0 | 0.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.0 | 1.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.0 | 0.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.0 | 0.4 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |